Selective Activation of the Adrenomedullin Receptors in Migraine

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2026
Adrenomedullin is a neuropeptide implicated in the pathogenesis of migraine. This study investigates whether its administration, after pre-treatment with erenumab (a CGRP-receptor blocking monoclonal antibody), can trigger migraine attacks in individuals with migraine without aura.
Epistemonikos ID: ad5b69300cc4405c9650c0c32bfcdd34b69a4b24
First added on: Mar 06, 2026